ELUCIDATING A NOVEL PATHWAY TARGETED BY HDAC INHIBITORS AND ITS UTILITY IN PROSTATE CANCER THERAPY

$570,798FY2009Department of the ArmyDOD

Duke University, Durham NC

Investigators